AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%
Market Cap$460.2B
LTM EPS
$3.6
YoY Growth
-6.3%
3Y CAGR
+131.3%
5Y CAGR
+28.4%
Stock quality & Intrinsic value
7/10
60.2% overvalued

AstraZeneca PLC EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
EPS
$218.0
$2.9
$3.9
$3.7
$4.2
$5.2
$5.6
$7.3
$5.0
$2.0
$1.0
$2.2
$2.8
$2.4
$1.7
$1.0
$2.4
$0.1
$2.1
$1.9
AZN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AZN and see if it's the right time to invest.
Dive in

AstraZeneca PLC (AZN) EPS comparison analysis

Crunching data... Almost there!

AZN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AstraZeneca PLC's EPS?

As of today, AstraZeneca PLC's last 12-month EPS is $3.6, based on the financial report for Dec 31, 2024 (Q4 2024).

2) What is AstraZeneca PLC's EPS growth rate?

Over the last year, AstraZeneca PLC's EPS growth was (6.3%). The average annual EPS growth rates for AstraZeneca PLC have been 7.6% over the past three years, 28.4% over the past five years.

3) Is AstraZeneca PLC's EPS growth rate Good?

Over the last year, AstraZeneca PLC's EPS growth was (6.3%), which is lower than industry growth of (0.0%). It indicates that AstraZeneca PLC's EPS growth is Bad.

4) How does AstraZeneca PLC's EPS growth rate compare to its peers?

Over the last year, AstraZeneca PLC's EPS growth was (6.3%), which is lower than peer median growth of 0.5%. The list of peers includes LLY, AMGN, MRK, NVS, JNJ, SNY, ABBV, PFE, GILD, BMY etc.